Biotech Strategy Blog
Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Immunotherapy
-
Dual CAR-T therapies: two engines, better mileage?
-
Protein Degraders Hit Their Stride
-
More than numbers
-
In a nutshell
-
Upping the Game
-
Beyond the antibody hype: small molecules show mixed results at ASCO25
-
Wired for Impact
-
Gunfight at the ASCO Corral
-
Breaking Barriers: ADCs cross into the brain as ASCO25 delivers surprises and disappointments
-
Finding the sweetspot
-
The Subtle Art of Bispecific Architecture
-
T Cell Engager Comeback: Why solid tumors may finally yield
-
Red and green flags for CytomX’s CX-2051 in CRC